SRTA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Strata Critical Medical Inc (SRTA) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, options sentiment is neutral to slightly positive, and the company's financial performance shows significant net income and EPS declines despite revenue growth. There are no strong positive catalysts or trading signals to justify immediate entry.
The technical indicators for SRTA are bearish. The MACD is below zero and negatively contracting, the RSI is neutral at 48.03, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 4.44, with key support at 4.241 and resistance at 4.638.
Revenue increased by 36.70% YoY in Q3 2025, and gross margin improved by 13.16% YoY, reflecting some operational improvements.
Net income dropped significantly by -3038.38% YoY, and EPS declined by -2433.33% YoY, indicating severe profitability challenges. Additionally, there is no recent news or significant trading activity from insiders, hedge funds, or Congress to act as a catalyst.
In Q3 2025, SRTA's revenue grew by 36.70% YoY to $49.3M, but net income dropped drastically by -3038.38% YoY to $57.4M. EPS also fell by -2433.33% YoY to 0.7. Gross margin improved to 23.56%, up 13.16% YoY, indicating some operational efficiency gains despite profitability issues.
No data available for analyst ratings or price target changes.
